The Company has entered into a strategic licensing advisory agreement with a leading international consultancy.

The firm boasts a track record of over 1,100 academic publications and has been recognized as a most innovative bioinformatics enterprise.

This collaboration will integrate market strategy analysis to optimize commercial evaluation and market access strategies for R&D projects, thereby accelerating the progress of international licensing.